跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞维那新吸入溶液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Revefenacin Inhalation Solution
Approved
化学药品
Revefenacin Inhalation Solution
MYLAN IRELAND LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jun 10, 2025
Approval ID
8kHbRcnjpMn
Company
MYLAN IRELAND LIMITED
Type
化学药品
Approval Details
Approval Id
8kHbRcnjpMn
Approval Number
国药准字HJ20250070
Generic Name
瑞维那新吸入溶液
Generic Name En
Revefenacin Inhalation Solution
Drug Type
化学药品
Dosage Form
吸入制剂
Strength
3ml:175μg
Reg Date
2025-06-10
Expired Date
2030-06-09
Company Name
MYLAN IRELAND LIMITED
Production Company Name
The Ritedose Corporation
Company Detail Path
/organization/mylan-ireland-limited
Production Company Detail Path
/organization/the-ritedose-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 10, 2025
Approval ID
8kHbRcnjpMn
Type
化学药品
Back to NMPA Approvals